ICU Medical, Incorporated (ICUI) Holdings Boosted by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 6.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,118 shares of the medical instruments supplier’s stock after purchasing an additional 68 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in ICU Medical were worth $268,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Smith Moore & CO. purchased a new position in ICU Medical during the fourth quarter worth approximately $254,000. Amalgamated Bank raised its stake in ICU Medical by 59.6% during the fourth quarter. Amalgamated Bank now owns 3,660 shares of the medical instruments supplier’s stock worth $840,000 after purchasing an additional 1,367 shares during the period. Raymond James Trust N.A. raised its stake in ICU Medical by 47.4% during the first quarter. Raymond James Trust N.A. now owns 1,480 shares of the medical instruments supplier’s stock worth $354,000 after purchasing an additional 476 shares during the period. Municipal Employees Retirement System of Michigan purchased a new position in ICU Medical during the fourth quarter worth approximately $914,000. Finally, Retirement Systems of Alabama raised its stake in ICU Medical by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 21,506 shares of the medical instruments supplier’s stock worth $4,938,000 after purchasing an additional 93 shares during the period. 92.90% of the stock is currently owned by institutional investors.

In other news, COO Christian B. Voigtlander sold 5,348 shares of the firm’s stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $227.59, for a total value of $1,217,151.32. Following the transaction, the chief operating officer now owns 4,732 shares of the company’s stock, valued at approximately $1,076,955.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 229 shares of the firm’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $231.43, for a total transaction of $52,997.47. Following the completion of the transaction, the director now directly owns 18,076 shares in the company, valued at approximately $4,183,328.68. The disclosure for this sale can be found here. In the last three months, insiders sold 12,318 shares of company stock worth $2,839,576. Insiders own 11.40% of the company’s stock.

Shares of ICUI stock opened at $225.27 on Thursday. ICU Medical, Incorporated has a 52 week low of $210.94 and a 52 week high of $321.70. The firm has a market capitalization of $4.62 billion, a PE ratio of 29.22 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, beating the Zacks’ consensus estimate of $1.96 by $0.39. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The business had revenue of $330.93 million for the quarter, compared to the consensus estimate of $318.97 million. During the same quarter last year, the firm posted $2.26 EPS. The business’s revenue for the quarter was down 11.0% compared to the same quarter last year. As a group, sell-side analysts forecast that ICU Medical, Incorporated will post 8.59 earnings per share for the current year.

A number of research firms have weighed in on ICUI. BidaskClub raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. Raymond James cut their price target on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a research note on Friday, March 1st. TheStreet downgraded shares of ICU Medical from a “b-” rating to a “c+” rating in a research note on Tuesday, March 19th. Finally, Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price target on the stock in a research note on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $281.00.

TRADEMARK VIOLATION NOTICE: “ICU Medical, Incorporated (ICUI) Holdings Boosted by Zurcher Kantonalbank Zurich Cantonalbank” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/05/16/icu-medical-incorporated-icui-holdings-boosted-by-zurcher-kantonalbank-zurich-cantonalbank.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: Is it Safe to Invest in Commodities?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.